Demens

Ugeskrift for Laeger

Volumn 159, Issue 20, 1997, Pages 2987-2989

  Waldemar, Gunhild ^a  

^a Neurocentret H:S Righospitalet ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031565467     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nordberg A, Winblad B, eds. Alzheimer's disease: advances in research and clinical practice. Acta Neurol Scand 1996; 93 (supplies).
2. Luxhøj A, Søgaard J, Sørensen LH, Kragh-Sørensen P. Plejebehov og omkostninger ved demenssygdom. Gerontol Samfund 1995; 11: 58-60.
3. Kopelman M, Crawford S. Not all memory clinics are dementia clinics. Neuropsychol Rehabil 1996; 6: 187-202.
4. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 47(suppl 5): 9-15.
5. West MJ, Coleman PD, Flood DG, Troncosco JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994; 344: 769-72.
6. Van Duijn CM. Epidemiology of the dementias, recent developments and new approaches. Neuroepidemiology 1996; 40: 478-88.
7. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's disease. Statement on use of apolipoprotein E testing for Alzheimer's Disease. Consensus statement. JAMA 1995; 274: 1627-9.
8. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological and diagnostic aspects. Cerebrovasc Brain Metab Rev 1995; 7: 89-130.
9. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high dose tacrine in patients with Alzheimers disease. The Tacrine Study Group. JAMA 1994; 271: 985-91.
10. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. Review article. Current concepts. N Engl J Med 1996; 335: 330-6.